Showing results (431-440 of 532) with videos related to

Sort By:
Pageof 54
European Heart Journal|January 18, 2021
Influence of neprilysin inhibition on the efficacy and safety of empagliflozin in patients with chronic heart failure and a reduced ejection fraction: the EMPEROR-Reduced trialMilton Packer, Stefan D Anker, Javed Butler, et al.
European Journal of Heart Failure|July 14, 2025
Coordinated expression of BMP10/ALK1/endoglin-proteins that drive embryonic cardiac and vascular morphogenesis-in patients with heart failure: The EMPEROR ProgramMilton Packer, Javed Butler, João Pedro Ferreira, et al.
The New England Journal of Medicine|February 14, 2007
Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stentsGregg W Stone, Jeffrey W Moses, Stephen G Ellis, et al.
JACC. Heart Failure|March 7, 2023
Comparison of Investigator-Reported and Centrally Adjudicated Heart Failure Outcomes in the EMPEROR-Reduced TrialPeter Carson, John R Teerlink, Michel Komajda, et al.
European Journal of Heart Failure|April 1, 2024
Body mass index and cardiorenal outcomes in the EMPEROR-Preserved trial: Principal findings and meta-analysis with the DELIVER trialNaveed Sattar, Javed Butler, Matthew M Y Lee, et al.
The New England Journal of Medicine|May 8, 2009
Paclitaxel-eluting stents versus bare-metal stents in acute myocardial infarctionGregg W Stone, Alexandra J Lansky, Stuart J Pocock, et al.
Circulation|August 30, 2021
Effect of Empagliflozin on Worsening Heart Failure Events in Patients With Heart Failure and Preserved Ejection Fraction: EMPEROR-Preserved TrialMilton Packer, Javed Butler, Faiez Zannad, et al.
JACC. Heart Failure|February 3, 2025
Comparison of Investigator-Reported and Centrally Adjudicated Heart Failure Outcomes in the EMPEROR-Preserved TrialPeter Carson, John R Teerlink, Michel Komajda, et al.
Clinical Cardiology|July 4, 2020
Long-term antithrombotic management patterns in Asian patients with acute coronary syndrome: 2-year observations from the EPICOR Asia studyBo Zheng, Yong Huo, Stephen W-L Lee, et al.
JAMA Cardiology|May 24, 2023
Safety and Efficacy of Empagliflozin and Diuretic Use in Patients with Heart Failure and Preserved Ejection Fraction: A Post Hoc Analysis of the EMPEROR-Preserved TrialJaved Butler, Muhammad Shariq Usman, Gerasimos Filippatos, et al.
Pageof 54